IP Library Granted Patent US 10,400,272
Granted Patent B1
US 10,400,272 · App. 16/355,361 · Granted Sep 3, 2019

Methods and compositions for stabilizing nucleic acid-nucleotide-polymerase complexes

Inventors: Morassa Mohseni Middleton (San Diego, CA); Mark C. Wallen (San Diego, CA); Pinar Iyidogan (San Diego, CA); Michael James Schmidt (San Diego, CA); Brittany A. Rohrman (La Jolla, CA); Ying Lin Liu (San Diego, CA); Fabian Block (San Diego, CA); Arnold Oliphant (Morgan Hill, CA)
Assignee: OMNIOME, INC.
C12Q1/6832C12Q1/6816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,400,272
App. No.
16/355,361
Granted
Sep 3, 2019
Kind
B1
Abstract

Methods, compositions, kits and apparatuses that include a fluid, the fluid containing a ternary complex and Li + , wherein the ternary complex includes a primed template nucleic acid, a polymerase, and a nucleotide cognate for the next correct base for the primed template nucleic acid molecule. As an alternative or addition to Li + , the fluid can contain betaine or a metal ion that inhibits polymerase catalysis such as Ca 2+ . In addition to Li + , the fluid can contain polyethylenimine (PEI) with or without betaine.

Claims (27)

1. A method of detecting a primed template nucleic acid, comprising the steps of:

(a) providing a mixture comprising a ternary complex, the ternary complex comprising a primed template nucleic acid, a polymerase, and a nucleotide cognate for the next base of the primed template nucleic acid,

wherein the mixture further comprises excess nucleotide of the same type present in the ternary complex;

(b) replacing the excess nucleotide with a fluid comprising Li + ; and

(c) detecting the ternary complex while it is in contact with the fluid comprising Li + .

2. The method of claim 1 , further comprising (d) identifying the next correct base for the primed template nucleic acid molecule from the result of step (c).

3. The method of claim 2 , further comprising (e) extending the primer of primed template nucleic acid.

4. The method of claim 3 , wherein the primer is extended by addition of a nucleotide comprising a reversible terminator moiety.

5. The method of claim 1 , wherein the primer of the primed template comprises a reversible terminator moiety.

6. The method of claim 5 , further comprising modifying or removing the reversible terminator moiety to deblock the primer.

7. The method of claim 6 , further comprising extending the deblocked primer.

8. The method of claim 7 , wherein the deblocked primer is extended by addition of a nucleotide comprising a reversible terminator moiety.

9. The method of claim 1 , wherein the ternary complex is immobilized on a solid support.

10. The method of claim 1 , wherein the nucleotide cognate comprises an exogenous label that is detected in step (c).

11. The method of claim 10 , wherein the mixture comprises nucleotide cognates for at least two different base types suspected of being present in the template nucleic acid.

12. The method of claim 11 , wherein the nucleotide cognates for the different base types comprise different exogenous labels, respectively.

13. The method of claim 1 , wherein the polymerase comprises an exogenous label that is detected in step (c).

14. The method of claim 1 , wherein the mixture further comprises excess polymerase of the same type present in the ternary complex.

15. The method of claim 14 , wherein step (c) comprises replacing the excess polymerase and the excess nucleotide with the fluid comprising Li + .

16. The method of claim 14 , wherein the excess polymerase is soluble in the fluid.

17. The method of claim 1 , wherein the excess nucleotide is soluble in the fluid.

18. The method of claim 1 , wherein step (b) comprises delivering to the ternary complex a fluid that comprises Li + and lacks nucleotides of the type present in the ternary complex, thereby replacing the excess nucleotide with the fluid.

19. The method of claim 1 , wherein the Li + is present at a concentration between 1 mM and 100 mM during step (c).

20. The method of claim 1 , wherein the fluid further comprises betaine.

21. The method of claim 1 , wherein the fluid further comprises polyethylenimine.

22. The method of claim 1 , wherein the concentration of ternary complex is greater than the concentration of free nucleotide in the fluid comprising Li + during the detecting in step (c), the free nucleotide being the type of nucleotide that is present in the ternary complex.

23. The method of claim 1 , wherein the concentration of ternary complex is greater than the concentration of free polymerase in the fluid comprising Li + during the detecting in step (c), the free polymerase being the type of polymerase that is present in the ternary complex.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 059278/0153 →
MERGER Recorded Feb 2, 2022
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 058952/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PREVIOUSLY RECORDED AT REEL: 049430 FRAME: 0752. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 18, 2019
From: MIDDLETON, MORASSA MOHSENI; WALLEN, MARK C.; IYIDOGAN, PINAR; SCHMIDT, MICHAEL JAMES; ROHRMAN, BRITTANY A.; LIU, YING LIN; BLOCK, FABIAN; OLIPHANT, ARNOLD
To: OMNIOME, INC.
Reel/Frame 049503/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: MI, MORASSA MOHSENI; WALLEN, MARK C.; IYIDOGAN, PINAR; SCHMIDT, MICHAEL JAMES; ROHRMAN, BRITTANY A.; LIU, YING LIN; BLOCK, FABIAN; OLIPHANT, ARNOLD
To: OMNIOME, INC.
Reel/Frame 049430/0752 →
Continuity (1)
Provisional Application 62662888 · Apr 26, 2018
Cited By (5)
US 12,241,891 US 12,404,549 US 12,435,370 US 12,509,669 US 12,540,350